Bone Graft Innovations Accelerate Growth in the Global Spine Biologics Market
The global spine biologics market is experiencing steady growth as healthcare providers increasingly adopt regenerative therapies and advanced biologic solutions to treat spinal disorders. Valued at US$ 2.4 billion in 2022, the market is projected to reach US$ 3.5 billion by 2031, expanding at a CAGR of 4.1% during the forecast period from 2023 to 2031. The growing prevalence of spinal...
0 Commentaires 0 Parts 7 Vue 0 Aperçu